Cargando…

Alpha E: No More Rejection?

Detalles Bibliográficos
Autores principales:	Kilshaw, Peter J., Higgins, Jonathan M.G.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2002
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194032/ https://www.ncbi.nlm.nih.gov/pubmed/12370249 http://dx.doi.org/10.1084/jem.20021404

Ejemplares similares

Plasma cell-rich acute rejection: A morphologic archetype of combined cellular and humoral rejection?
por: Mubarak, M.
Publicado: (2016)

Conspiracist Ideation as a Predictor of Climate-Science Rejection: An Alternative Analysis
por: Dixon, Ruth M., et al.
Publicado: (2015)

The Rejection Sensitivity Model: Sexual Minority Adolescents in Context
por: Baams, Laura, et al.
Publicado: (2019)

Rituximab use in late antibody-mediated rejection
por: Bansal, S. B.
Publicado: (2016)

Getting to know our non-traditional and rejected medical school applicants
por: Wouters, Anouk
Publicado: (2020)

Value Assessment in Cystic Fibrosis: ICER’s Rejection of the Axioms of Fundamental Measurement
por: Langley, Paul C
Publicado: (2020)

How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?
por: Crew, R. John, et al.
Publicado: (2019)

Why public health people are more worried than excited over e-cigarettes
por: Pisinger, Charlotta
Publicado: (2014)

More Dengue, More Questions
por: Halstead, Scott B.
Publicado: (2005)

Are we ready to implement non-invasive tests to detect allograft rejection in a daily praxis?
por: Viklicky, Ondrej
Publicado: (2019)

Novelty in research: A common reason for manuscript rejection!
por: Kumar, Nishant, et al.
Publicado: (2023)

More is More: Are We Delivering Enough LLINs?
por: Koenker, Hannah
Publicado: (2018)

African Biochemists Plan More Collaboration
por: Campbell, Peter N.
Publicado: (2001)

Human ES cell-derived dendritic cells: Meeting the challenge of immune rejection in allogeneic cell therapy
por: Zenke, Martin
Publicado: (2020)

Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?
por: Muthukumar, Thangamani, et al.
Publicado: (2022)

Cell therapy for refractory angina: time for more ACTion
por: Psaltis, Peter J, et al.
Publicado: (2011)

Curriculum reform: the more things change, the more they stay the same?
por: Hawick, Lorraine, et al.
Publicado: (2016)

The more health policies change, the more they change the same way
por: Chinitz, David
Publicado: (2019)

GLP-1–Based Therapies and the Exocrine Pancreas: More Light, or Just More Heat?
por: Gale, Edwin A.M.
Publicado: (2012)

Placebo for depression: we need to improve the quality of scientific information but also reject too simplistic approaches or ideological nihilism
por: Cipriani, Andrea, et al.
Publicado: (2014)

Non-invasive screening for sub-clinical antibody-mediated rejection as a new tool for indication of kidney allograft biopsy
por: Kozakowski, Nicolas
Publicado: (2019)

Alpha the versatile: Guardians of the islets
por: Kawamori, Dan
Publicado: (2018)

Why illness is more important than disease in old age
por: Olde Rikkert, Marcel G M, et al.
Publicado: (2022)

Zika Virus Serology: More Diagnostic Targets, more Reliable Answers?
por: Panning, Marcus
Publicado: (2017)

The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
por: Allred, D Craig, et al.
Publicado: (2004)

Low-Density Lipoprotein Cholesterol Treatment Rates in High Risk Patients: More Disappointment Despite Ever More Refined Evidence-Based Guidelines.
por: Toth, Peter P.
Publicado: (2021)

Fluoridation cessation: More science from Alberta
por: McLaren, Lindsay, et al.
Publicado: (2017)

Recently published papers: More about EGDT, experimental therapies and some inconvenient truths
por: Ball, Jonathan
Publicado: (2007)

When more is better
por: Pichard, Claude
Publicado: (2014)

Pneumonia — Forgotten no more
por: Chapman, Penelope L.
Publicado: (2013)

Commentary: Forgotten no more
por: Hirji, Sameer A., et al.
Publicado: (2020)

Is there more to glycaemic control than meets the eye?
por: Chase, J Geoffrey, et al.
Publicado: (2007)

Commentary: In the absence of convincing evidence, more is not better
por: Falasa, Matheus P., et al.
Publicado: (2020)

Vasopressin and ischaemic heart disease: more than coronary vasoconstriction?
por: Asfar, Pierre, et al.
Publicado: (2009)

Recently published papers: a little less ventilation, a little more oxygen please?
por: Ball, Jonathan
Publicado: (2008)

Lighting Up Alpha-synuclein Oligomers
por: Richter, Franziska
Publicado: (2018)

Death of the septic monocyte: is more better?
por: Moraes, Theo J, et al.
Publicado: (2006)

Alpha-synuclein–mediated DNA damage, STING activation, and neuroinflammation in Parkinson’s disease
por: Standaert, David G., et al.
Publicado: (2022)

Commentary: Robotic-assisted subxiphoid thymectomy: The more things change, the more they stay the same
por: Lazzaro, Richard S., et al.
Publicado: (2020)

Circular mRNAs: More stable RNAs lead to more persistent protein expression
por: Zhang, Jiayu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_997m4khtotich3cf926ijhflso